Analyst Consensus ?
ConsensusBuy21 ratings
Bullish1781.0%
Neutral419.0%
Bearish00.0%
1 unmapped firm rating excluded from the percentages.
FN2 Earnings Intelligence
Expand Energy Corporation (EXE) analyst consensus, price targets, and firm-level rating history from FN2 Research.
1 unmapped firm rating excluded from the percentages.
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 29, 2026. Not an FN2 forecast.
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| UBS | Buy | Buy | Maintain | Oct 15, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | Oct 15, 2026 |
| Mizuho | Outperform | Outperform | Maintain | Oct 6, 2026 |
| Truist Securities | Buy | Buy | Maintain | Oct 5, 2026 |
| Raymond James | Strong Buy | Strong Buy | Maintain | Oct 5, 2026 |
| Bernstein | Outperform | Outperform | Maintain | Oct 5, 2026 |
| Jefferies | Buy | Buy | Maintain | Oct 2, 2026 |
| Goldman Sachs | Buy | Buy | Maintain | Aug 26, 2026 |
| Johnson Rice | Accumulate | Buy | Maintain | Aug 17, 2026 |
| Barclays | Equal Weight | Equal Weight | Maintain | Aug 17, 2026 |
| Benchmark | Buy | Buy | Maintain | Aug 12, 2026 |
| Citigroup | Buy | Buy | Maintain | Jul 9, 2026 |
| William Blair | Market Perform | Outperform | Downgrade | Apr 30, 2026 |
| Keybanc | Overweight | Downgrade | Apr 2, 2026 | |
| Piper Sandler | Overweight | Overweight | Maintain | Mar 12, 2026 |
| Stephens & Co. | Overweight | Overweight | Maintain | Feb 18, 2026 |
| Scotiabank | Sector Outperform | Sector Outperform | Maintain | Oct 9, 2025 |
| Roth Capital | Neutral | Buy | Downgrade | Aug 18, 2025 |
| Wells Fargo | Equal Weight | Equal Weight | Maintain | Jul 15, 2025 |
| TD Cowen | Buy | Hold | Upgrade | Apr 8, 2025 |
| JP Morgan | Overweight | Overweight | Maintain | Mar 13, 2025 |
| RBC Capital | Outperform | Outperform | Maintain | Jan 14, 2025 |
Upside is calculated against the persisted current price $91.29. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Goldman Sachs | Analyst unavailable | $117 | $92.67 | +28.2% | Oct 20, 2026 |
| UBS | Analyst unavailable | $120 | $91.11 | +31.4% | Oct 15, 2026 |
| Scotiabank | Analyst unavailable | $111 | $91.11 | +21.6% | Oct 14, 2026 |
| Mizuho Securities | Analyst unavailable | $138 | $86.43 | +51.2% | Oct 6, 2026 |
| Raymond James | John Freeman | $141 | $85.4 | +54.5% | Oct 5, 2026 |
| Truist Financial | Analyst unavailable | $120 | $85.39 | +31.4% | Oct 5, 2026 |
| Bernstein | Bob Brackett | $127 | $85.52 | +39.1% | Oct 5, 2026 |
| UBS | Analyst unavailable | $122 | $85.97 | +33.6% | Oct 2, 2026 |
| Jefferies | Analyst unavailable | $136 | $85.96 | +49.0% | Oct 1, 2026 |
| UBS | Josh Silverstein | $129 | $94.83 | +41.3% | Sep 14, 2026 |
| Stifel Nicolaus | David Deckelbaum | $135 | $96.62 | +47.9% | Sep 9, 2026 |
| Raymond James | John Freeman | $147 | $98.19 | +61.0% | Sep 9, 2026 |
| Goldman Sachs | Analyst unavailable | $113 | $94.66 | +23.8% | Aug 26, 2026 |
| Morgan Stanley | Analyst unavailable | $129 | $96.4 | +41.3% | Aug 19, 2026 |
| Johnson Rice | Analyst unavailable | $125 | $93.62 | +36.9% | Aug 17, 2026 |
| Barclays | Analyst unavailable | $107 | $94.78 | +17.2% | Aug 17, 2026 |
| UBS | Josh Silverstein | $124 | $91.24 | +35.8% | Jul 30, 2026 |
| Roth Capital | Analyst unavailable | $93 | $93.04 | +1.9% | Jul 29, 2026 |
| Wolfe Research | Doug Leggate | $114 | $91.96 | +24.9% | Jul 29, 2026 |
| Truist Financial | Analyst unavailable | $117 | $86.74 | +28.2% | Jul 10, 2026 |
| UBS | Josh Silverstein | $127 | $87.1 | +39.1% | Jul 10, 2026 |
| Morgan Stanley | Analyst unavailable | $131 | $88.47 | +43.5% | Jun 29, 2026 |
| Barclays | Analyst unavailable | $110 | $97.94 | +20.5% | May 26, 2026 |
| Morgan Stanley | Analyst unavailable | $139 | $97.08 | +52.3% | May 22, 2026 |
| Truist Financial | Analyst unavailable | $133 | $99.5 | +45.7% | Apr 9, 2026 |
| Morgan Stanley | Analyst unavailable | $141 | $113.5 | +54.5% | Mar 27, 2026 |
| UBS | Analyst unavailable | $135 | $106.04 | +47.9% | Feb 23, 2026 |
| Wells Fargo | Analyst unavailable | $123 | $108.06 | +34.7% | Feb 23, 2026 |
| Barclays | Betty Jiang | $125 | $108.06 | +36.9% | Feb 23, 2026 |
| Jefferies | Lloyd Byrne | $141 | $99.52 | +54.5% | Feb 19, 2026 |
| Stephens | Analyst unavailable | $146 | $102.75 | +59.9% | Feb 18, 2026 |
| Piper Sandler | Analyst unavailable | $137 | $108.82 | +50.1% | Jan 28, 2026 |
| Barclays | Analyst unavailable | $126 | $109.85 | +38.0% | Jan 21, 2026 |
| Stephens | Analyst unavailable | $140 | $99.88 | +53.4% | Jan 20, 2026 |
| UBS | Josh Silverstein | $150 | $105.61 | +64.3% | Jan 8, 2026 |
| Jefferies | Analyst unavailable | $143 | $106.66 | +56.6% | Jan 8, 2026 |
| Bernstein | Analyst unavailable | $144 | $109.77 | +57.7% | Jan 5, 2026 |
| UBS | Analyst unavailable | $154 | $113.82 | +68.7% | Dec 12, 2025 |
| Mizuho Securities | Nitin Kumar | $142 | $114.31 | +55.5% | Dec 12, 2025 |
| UBS | Analyst unavailable | $132 | $100.41 | +44.6% | Oct 30, 2025 |
| Morgan Stanley | Devin McDermott | $135 | $100.33 | +47.9% | Oct 14, 2025 |
| UBS | Josh Silverstein | $131 | $101.76 | +43.5% | Oct 13, 2025 |
| Scotiabank | Analyst unavailable | $150 | $106.84 | +64.3% | Oct 9, 2025 |
| Barclays | Analyst unavailable | $136 | $107.73 | +49.0% | Oct 7, 2025 |
| Mizuho Securities | Nitin Kumar | $136 | $95.58 | +49.0% | Sep 15, 2025 |
| Roth Capital | Analyst unavailable | $125 | $104.21 | +36.9% | Jul 30, 2025 |
| Jefferies | Lloyd Byrne | $135 | $116.46 | +47.9% | Jun 14, 2025 |
| KeyBanc | Tim Rezvan | $135 | $116.46 | +47.9% | Jun 13, 2025 |
| Stephens | Mike Scialla | $118 | $104.23 | +29.3% | Apr 15, 2025 |
| Piper Sandler | Analyst unavailable | $101 | $96.24 | +10.6% | Mar 6, 2025 |
| Barclays | Analyst unavailable | $117 | $98.88 | +28.2% | Feb 28, 2025 |
| Roth Capital | Leo Mariani | $116 | $106 | +27.1% | Jan 23, 2025 |
| Morgan Stanley | Devin McDermott | $136 | $107.35 | +49.0% | Jan 22, 2025 |
| Wolfe Research | Doug Leggate | $146 | $99.78 | +59.9% | Jan 3, 2025 |
| Citigroup | Paul Diamond | $100 | $88.7 | +9.5% | Oct 30, 2024 |
| Stephens | Mike Scialla | $86 | $85.73 | -5.8% | Oct 30, 2024 |
| Mizuho Securities | Nitin Kumar | $110 | $87.36 | +20.5% | Oct 30, 2024 |
| Stephens | Mike Scialla | $85 | $86.46 | -6.9% | Oct 17, 2024 |
| Williams Trading | Gabriele Sorbara | $87 | $86.62 | -4.7% | Oct 15, 2024 |
| Mizuho Securities | Nitin Kumar | $105 | $87.57 | +15.0% | Oct 11, 2024 |
Track every rating change on EXE the moment it posts. Free to start.
Start freeOne email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.